Geistek Pharma SL
"Geistek Pharmaceuticals es una empresa española fundada en Madrid para dar solución a uno de los campos de mayor crecimiento en la industria: Las terapias avanzadas y los ensayos clínicos.
En Geistek estamos orgullosos de la calidad de nuestro equipo humano y de nuestros socios, todos ellos centrados en lo más importante: conseguir que la ciencia de vanguardia esté lista para los pacientes que más lo necesitan.
Proporcionamos apoyo a los ensayos clínicos y a los negocios para las terapias avanzadas en desarrollo con el fin de lograr lo que creemos: dar vida a la ciencia"
Extra Info
Title: Home | We Bring Science To Life - Geistek Pharma
URL Source: https://geistek.com/
Markdown Content:
Leaders in
Oncology Clinical Research
At Geistek, we are the link between innovation and clinical practice. Our mission is to transform the latest advances in research into effective treatments that improve the lives of patients globally.
Transformational Innovation
We develop innovative clinical research designs that optimize outcomes and accelerate new therapies to market. We implement personalized approaches using biomarkers to tailor treatments to each patient's specific needs.
Strategic Connection
We act as the bridge that links advanced research with daily clinical practice, ensuring that the latest innovations translate into real benefits for patients. We collaborate closely with leading pharmaceutical and biotech companies around the world, leveraging our research and development capabilities.
WE ARE THE NEXUS
Unmatched Experience
Our team is composed of oncology and rare diseases specialists with extensive experience in innovative research and clinical practice.
We remain at the forefront of the latest advances in cancer research and treatment.
Innovative Solutions
We are dedicated to developing and implementing revolutionary research designs that transform clinical practice.
Our focus on personalized medicine and targeted therapies improves patient outcomes.
Global Reach and Impact
Our extensive network of collaborators, including leading pharmaceutical and biotechnology companies, enables us to drive significant advances in oncology and rare diseases.
We have a proven track record of successful clinical trials and the implementation of innovative therapies.
Latest news
Tecartus
mayo 10, 2022
INTRODUCTION Tecartus is a new advanced therapy approved to treat adults with mantle cell lymphoma (MCL)¹. This disease is a lymphatic system cancer. Specifically, it
KYMRIAH, AN ANTI-CD19 CAR-T THERAPY
abril 19, 2022
INTRODUCTION Kymriah (Novartis) is an advanced therapy medicine that belongs to the gene therapyproduct category. It is approved for B-cell acute lymphoblastic leukemia (ALL) in
Contact us
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. You can review our Cookies Policy and our Privacy Policy.